Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model

Cancer
S X CavanaughM Fuss

Abstract

The goal of the current study was to analyze the prognostic value of early prostate-specific antigen (PSA) kinetics, with PSA assessed as reaching or failing to reach discrete threshold values at fixed time points during follow-up after external-beam radiotherapy (EBRT) for prostate carcinoma. The authors conducted a retrospective review of PSA follow-up for 839 patients treated between May 1987 and December 2000 at the Cleveland Clinic Foundation (Cleveland, OH). They also assessed the impact on bRFS of PSA levels lower than defined threshold values at given time points during follow-up. During a median follow-up of 74 months (range, 24-189 months), 540 patients (64.4%) maintained bRFS, whereas 299 patients (35.6%) did not maintain bRFS. The median nadir among patients with sustained bRFS was 0.4 ng/mL, with a median time to nadir of 28.9 months. Patients who did not maintain bRFS reached a median nadir of 1.3 ng/mL at a median of 15 months (P < 0.0001 for both nadir level and time to nadir). Reaching PSA thresholds of 3.0, 2.0, 1.0, 0.5, and 0.2 ng/mL at any time during follow-up was correlated with improved bRFS (P < 0.0001, each threshold). Patients whose PSA levels crossed the appropriate thresholds within 3 and 6 months o...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·G K Zagars
Nov 1, 1982·International Journal of Radiation Oncology, Biology, Physics·N RangalaA Lopes da Conceicao
Jan 1, 1994·The Prostate. Supplement·G R Blackledge, K Lowery
Feb 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G K Zagars, A Pollack
Oct 23, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G K Zagars, A Pollack
Jun 11, 1999·The Urologic Clinics of North America·M A CarducciJ B Nelson
Sep 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A V D'AmicoJ P Richie
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·M W KattanL Potters
Aug 3, 2001·International Journal of Radiation Oncology, Biology, Physics·J M TaylorH M Sandler
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Alan PollackIsaac Rosen
Sep 24, 2002·International Journal of Radiation Oncology, Biology, Physics·Torunn I YockJohn J Coen
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Janice K RyuJames D Cox
May 9, 2003·The Urologic Clinics of North America·Peter W SwindlePeter T Scardino
Sep 10, 2003·World Journal of Urology·Alan PollackRobert A Price
Sep 18, 2003·Journal of the National Cancer Institute·Anthony V D'AmicoMing-Hui Chen
Oct 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Deborah A KubanAnthony L Zietman

❮ Previous
Next ❯

Citations

Dec 21, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R AlmuftiB You
Feb 20, 2016·Journal of Pain and Symptom Management·Gwen K WyattJames Herman
Oct 27, 2004·Expert Opinion on Biological Therapy·Svend O FreytagMyung Chung
Jun 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Michael J ZelefskyVenkatraman E Seshan
Nov 4, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Daniel E SotoHoward M Sandler
May 17, 2007·Journal of Clinical Ultrasound : JCU·Robert E KrischPeter H Arger
Mar 1, 2006·International Journal of Radiation Oncology, Biology, Physics·Philippe NickersJean-Marie Deneufbourg
Sep 20, 2005·International Journal of Radiation Oncology, Biology, Physics·Mark K BuyyounouskiAlan Pollack
Oct 4, 2005·International Journal of Radiation Oncology, Biology, Physics·Michael E RayDeborah A Kuban
Sep 26, 2013·American Journal of Clinical Oncology·Skyler B JohnsonDaniel A Hamstra
Mar 17, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Joelle HelouGerard Morton
Feb 9, 2019·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Elton Trigo Teixeira LeiteGustavo Nader Marta
Jul 16, 2005·Scandinavian Journal of Urology and Nephrology. Supplementum·Ulf-Håkan StenmanPeter Ekman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.